Pure Global

Pulmonaryhypertension in Copd at Different Levels of Smoking - Trial NCT06031311

Access comprehensive clinical trial information for NCT06031311 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 138 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06031311
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06031311
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Pulmonaryhypertension in Copd at Different Levels of Smoking
Clinical Characteristics and Predictors of Pulmonary Hypertension in COPD at Different Levels of Smoking

Study Focus

Pulmonary Hypertension

Echocardiography and HRCT

Observational

diagnostic test

Sponsor & Location

Assiut University

Timeline & Enrollment

N/A

Oct 01, 2023

Dec 01, 2024

138 participants

Primary Outcome

Predictors of pulmonary hypertension in COPD patients

Summary

To identify Predictors of pulmonary hypertension in COPD patients and its relation to
 different levels of smoking

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT06031311

Non-Device Trial